Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized dose-finding trial of intranasal GHB11L1 in healthy adults
2009-015902-20Phase 2Completed
- Sponsor
- Green Hills Biotechnology
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GHB11L1 in influenza A virus infection (H1N1) (4 arms), sponsored by Green Hills Biotechnology. Primary endpoint: Immunogenicity (primary). Started Oct 2009; status: completed.
02
Drugs
GHB11L1
03
Conditions
influenza A virus infection (H1N1)
Beyond the preview
Go deeper on 2009-015902-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015902-20.